Press Releases
BioAsia 2013 concludes with international partnerships impactful discussions on promoting Biosimilars & Biologics
The 10th edition of BioAsia, BioAsia 2013, Asiaās biggest technology and bio-business platform, which commenced on 28th January 2013 concluded on Wednesday. The valedictory ceremony was attended by eminent personalities including Dr. D. Purandeswari,...
Press Releases
Adocia announces its phase III development program for the treatment of diabetic foot ulcer
Adocia , a biotechnology company specialized in the development of ābest-in-classā medicines from already approved therapeutic proteins announces today the Ā phase III development program of its product, BioChaperone(R) PDGF-BB for the treatment of diabetic foot ulcer (DFU). ...
Press Releases
Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders
Ā Athena Diagnostics a leader in neurological diagnostics today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders including hereditary neuropathy neuromuscular disease epilepsy and certain movement disorders. ...
Press Releases
Tech Innovations Drive Big Growth in $60 Billion Drug Delivery Market
The next generation of advanced pharmaceutical technologies could be poised to fuel remarkable growth in the $60 billion global drug delivery market and Rainbow Biosciencesāthe biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC)āplans to be right in the middle...
Press Releases
Trio Clinical Resourcing Launches New Website
Trio Clinical Resourcing an international biopharmaceutical and medical device resourcing company and a wholly owned subsidiary of Aptiv Solutions announced today the launch of its new company website at www.trioclinical.com. The new website is designed and updated with...
Press Releases
STENTYS Self-ApposingĀ® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials
STENTYS (FR0010949404 ā STNT) a medical technology company commercializing in Europe the world's first and only Self-ApposingĀ® Stent to treat acute myocardial infarction (AMI) announced today one-year results of the APPOSITION III clinical trial in 1000 patients post...
Press Releases
Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers
Saint-Gobain Performance Plastics has completed the acquisition of Applied Bioprocess Containers a U.S.-based supplier of single use containers and fluid transfer systems for the biopharmaceutical industry. Based in Plymouth Minnesota Applied Bioprocess Containers specializes...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read